93 related articles for article (PubMed ID: 9219842)
1. Lack of phospholipase A2 mutations in neuroblastoma, melanoma and colon-cancer cell lines.
Haluska FG; Thiele C; Goldstein A; Tsao H; Benoit EP; Housman D
Int J Cancer; 1997 Jul; 72(2):337-9. PubMed ID: 9219842
[TBL] [Abstract][Full Text] [Related]
2. Secretory type II phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa.
Praml C; Amler LC; Dihlmann S; Finke LH; Schlag P; Schwab M
Oncogene; 1998 Oct; 17(15):2009-12. PubMed ID: 9788445
[TBL] [Abstract][Full Text] [Related]
3. Variants at the secretory phospholipase A2 (PLA2G2A) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours.
Tomlinson IP; Beck NE; Neale K; Bodmer WF
Ann Hum Genet; 1996 Sep; 60(5):369-76. PubMed ID: 8912789
[TBL] [Abstract][Full Text] [Related]
4. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis.
Cormier RT; Hong KH; Halberg RB; Hawkins TL; Richardson P; Mulherkar R; Dove WF; Lander ES
Nat Genet; 1997 Sep; 17(1):88-91. PubMed ID: 9288104
[TBL] [Abstract][Full Text] [Related]
5. Human homologue of a candidate for the Mom1 locus, the secretory type II phospholipase A2 (PLA2S-II), maps to 1p35-36.1/D1S199.
Praml C; Savelyeva L; Le Paslier D; Siracusa LD; Buchberg AM; Schwab M; Amler LC
Cancer Res; 1995 Dec; 55(23):5504-6. PubMed ID: 7585622
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the secretory phospholipase A2 gene, a candidate of Mom1 gene, in neuroblastomas.
Kawamata N; Seriu T; Bartram CR; Koeffler HP
Cancer Lett; 1997 Jan; 111(1-2):71-5. PubMed ID: 9022130
[TBL] [Abstract][Full Text] [Related]
7. Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP.
Nimmrich I; Friedl W; Kruse R; Pietsch S; Hentsch S; Deuter R; Winde G; Müller O
Hum Genet; 1997 Sep; 100(3-4):345-9. PubMed ID: 9272153
[TBL] [Abstract][Full Text] [Related]
8. Human Krüppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene?
Maris JM; Jensen J; Sulman EP; Beltinger CP; Allen C; Biegel JA; Brodeur GM; White PS
Eur J Cancer; 1997 Oct; 33(12):1991-6. PubMed ID: 9516840
[TBL] [Abstract][Full Text] [Related]
9. Three secretory phospholipase A(2) genes that map to human chromosome 1P35-36 are not mutated in individuals with attenuated adenomatous polyposis coli.
Spirio LN; Kutchera W; Winstead MV; Pearson B; Kaplan C; Robertson M; Lawrence E; Burt RW; Tischfield JA; Leppert MF; Prescott SM; White R
Cancer Res; 1996 Mar; 56(5):955-8. PubMed ID: 8640784
[TBL] [Abstract][Full Text] [Related]
10. Absence of secretory phospholipase A2 gene alterations in human colorectal cancer.
Riggins GJ; Markowitz S; Wilson JK; Vogelstein B; Kinzler KW
Cancer Res; 1995 Nov; 55(22):5184-6. PubMed ID: 7585570
[TBL] [Abstract][Full Text] [Related]
11. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.
MacPhee M; Chepenik KP; Liddell RA; Nelson KK; Siracusa LD; Buchberg AM
Cell; 1995 Jun; 81(6):957-66. PubMed ID: 7781071
[TBL] [Abstract][Full Text] [Related]
12. Deletion mapping in breast tumor cell lines points to two distinct tumor-suppressor genes in the 1p32-pter region, one of deleted regions (1p36.2) being located within the consensus region of LOH in neuroblastoma.
Bieche I; Khodja A; Lidereau R
Oncol Rep; 1998; 5(1):267-72. PubMed ID: 9458380
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the Mom1 modifier of intestinal neoplasia in mice.
Gould KA; Dove WF
Exp Lung Res; 1998; 24(4):437-53. PubMed ID: 9659576
[TBL] [Abstract][Full Text] [Related]
14. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
[TBL] [Abstract][Full Text] [Related]
15. Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas.
Okawa ER; Gotoh T; Manne J; Igarashi J; Fujita T; Silverman KA; Xhao H; Mosse YP; White PS; Brodeur GM
Oncogene; 2008 Jan; 27(6):803-10. PubMed ID: 17667943
[TBL] [Abstract][Full Text] [Related]
16. Strain differences of rats in the susceptibility to aberrant crypt foci formation by 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine: no implication of Apc and Pla2g2a genetic polymorphisms in differential susceptibility.
Ishiguro Y; Ochiai M; Sugimura T; Nagao M; Nakagama H
Carcinogenesis; 1999 Jun; 20(6):1063-8. PubMed ID: 10357789
[TBL] [Abstract][Full Text] [Related]
17. Detailed molecular analysis of 1p36 in neuroblastoma.
White PS; Thompson PM; Seifried BA; Sulman EP; Jensen SJ; Guo C; Maris JM; Hogarty MD; Allen C; Biegel JA; Matise TC; Gregory SG; Reynolds CP; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):37-41. PubMed ID: 11464901
[TBL] [Abstract][Full Text] [Related]
18. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
19. The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64.
Cormier RT; Bilger A; Lillich AJ; Halberg RB; Hong KH; Gould KA; Borenstein N; Lander ES; Dove WF
Oncogene; 2000 Jun; 19(28):3182-92. PubMed ID: 10918573
[TBL] [Abstract][Full Text] [Related]
20. Genomic structure and mutational analysis of the human KIF1Balpha gene located at 1p36.2 in neuroblastoma.
Chen YY; Takita J; Chen YZ; Yang HW; Hanada R; Yamamoto K; Hayashi Y
Int J Oncol; 2003 Sep; 23(3):737-44. PubMed ID: 12888911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
